Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Melanoma × daromun × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Dacarbazine 24 Nivolumab 20 pembrolizumab 17 Ipilimumab 15 Interferon-alpha 10 trametinib 8 dabrafenib 7 aldesleukin 7 Vemurafenib 7 Temozolomide 7 Introns 6 Interferon alpha-2 6 Interleukin-2 5 Cisplatin 5 binimetinib 4 Radiotherapy 4 Chemotherapy, Adjuvant 4 encorafenib 3 cobimetinib 3 cemiplimab 3 Vinblastine 3 Specimen Handling 3 Sodium Chloride 3 Radiosurgery 3 Paclitaxel 3 Opdualag 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 CTLA-4 Antigen 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03567889 2025-12-17

NeoDREAM

Philogen S.p.A.

Phase 3 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡